BOPA Abstract deadline EXTENDED TO 9am Monday 10th August 2020

You spoke – we listened

The deadline for abstracts for this year’s virtual conference has been extended. Delegates are invited to present results of their clinical and technical work as a poster with some selected for oral presentation. The author/s should submit via the BOPA website by 9am Monday 10th August 2020. Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal. The winning presentation will receive a prize worth £2,000 to attend an international conference.

Further information can be found on the abstract section of the website HERE.

Late Breaking Abstracts: This year we will allow delegates to submit late breaking abstracts. Abstracts relating to the Covid-19 pandemic will be considered for presentation by the research committee if completed work is submitted after the 10th August deadline. Please contact the A&R committee to request a late submission relating to Covid-19.

Latest News

By BOPA Committee on 10th August 2020

Clinical Pharmacy Congress – NOW Virtual for 2020

#CPC UPDATE: After careful consideration & in light of the ongoing pandemic, the organisers of @CPCongress have made the decision to postpone CPC 20 to 14/15 May 21 – the…

Read article
By BOPA Committee on 3rd August 2020

Introduction to Oncology Course – AVAILABLE ONLINE NOW

The BOPA Introduction to Oncology Virtual seminar series is now available ONLINE.  As a BOPA member you can watch the seminars anytime you want and also a new QUIZ is…

Read article
By BOPA on 3rd August 2020

What can I expect from a BOPA virtual conference?

Click here for the video from one of the BOPA chairs – Emma Foreman about what to expect.

Read article
By UK Chemotherapy Board on 30th July 2020

Personalised Medicine Approach For Fluoropyrimidine-based Therapies

Please see new guidance from the UK Chemotherapy Board on ‘Personalised Medicine Approach For Fluoropyrimidine-based Therapies’. Objective of document: To provide clinical staff with guidance as to which patients should…

Read article

23rd BOPA Symposium 2020

Friday 9th to Sunday 11th October 2020 – VIRTUAL

Everything you need to know